Tanke Biosciences

(OTC) TNBI

Current Price$0.01

Market Cap$327,600

Since IPO (2011)-99%

5 Year-84%

1 Year-60%

1 Month-63%

Tanke Biosciences Financials at a Glance

Market Cap

$327,600

Revenue (TTM)

$8.43K

Net Income (TTM)

$213.82K

EPS (TTM)

$-0.01

P/E Ratio

-1.79

Dividend

$0.00

Beta (Volatility)

-0.17 (Low)

Dividend

$0.00

Beta (Volatility)

-0.17 (Low)

Price

$0.01

Volume

12,500

Open

$0.01

Price

$0.01

Volume

12,500

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.06

Dividend

$0.00

Beta (Volatility)

-0.17 (Low)

Price

$0.01

Volume

12,500

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.06

TNBI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tanke Biosciences

Industry

Commercial Services and Supplies

Sector

Industrials

CEO

Vincent W. Renz, Jr., MBA

Website

www.tanke-bio.com

Headquarters

Las Vegas, 510627, CN

TNBI Financials

Key Financial Metrics (TTM)

Gross Margin

88%

Operating Margin

-24%

Net Income Margin

-25%

Return on Equity

Return on Capital

46%

Return on Assets

-3%

Earnings Yield

-55.87%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$327.60K

Shares Outstanding

21.84M

Volume

12.50K

Avg. Volume

898.594

Financials (TTM)

Gross Profit

$6.87K

Operating Income

$257.87K

EBITDA

$256.30K

Operating Cash Flow

$36.99K

Capital Expenditure

$3.00

Free Cash Flow

$36.99K

Cash & ST Invst.

$6.01K

Total Debt

$140.00K

Tanke Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$327.60K

N/A

Market Cap/Employee

$2.52K

N/A

Employees

130

N/A

Net Income

$38.34K

+61.2%

EBITDA

$35.69K

+60.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$130.44K

-28.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$140.00K

+0.0%

Return on Assets

-2.74%

N/A

Return on Invested Capital

46.09%

N/A

Free Cash Flow

$870.00

-109.2%

Operating Cash Flow

$869.00

-109.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IVFZFMapath Capital Corp.

IVFZFMapath Capital Corp.$0.01+0.00%

AIKOAlternative Investment Corporation

AIKOAlternative Investment Corporation$1.13+0.00%

NGCGNew Generation Consumer Group, Inc.

NGCGNew Generation Consumer Group, Inc.$0.00+6.67%

QYBXQian Yuan Baixing, Inc.

QYBXQian Yuan Baixing, Inc.$0.01+33.17%

IHAIInnovative Holdings Alliance, Inc.

IHAIInnovative Holdings Alliance, Inc.$0.09+0.00%

CRVHChilco River Holdings, Inc.

CRVHChilco River Holdings, Inc.$0.01-10.00%

LICHLivechain Inc.

LICHLivechain Inc.$0.01+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$15.47+0.09%

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

ACHRArcher Aviation

ACHRArcher Aviation$6.36+0.04%

Questions About TNBI

What is the current price of Tanke Biosciences?

Tanke Biosciences is trading at $0.02 per share.

What is the 52-week range for Tanke Biosciences?

Over the past 52 weeks, Tanke Biosciences has traded between $0.02 and $0.06.

How much debt does Tanke Biosciences have?

As of the most recent reporting period, Tanke Biosciences reported total debt of $140,000.

How much cash does Tanke Biosciences have on hand?

Tanke Biosciences reported $9,556 in cash and cash equivalents in its most recent financial results.

What is Tanke Biosciences’s dividend yield?

Tanke Biosciences does not currently have a dividend yield.

Tanke Biosciences

Tanke Biosciences Financials at a Glance

TNBI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Tanke Biosciences

TNBI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Tanke Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TNBI

What is the current price of Tanke Biosciences?

What is the 52-week range for Tanke Biosciences?

How much debt does Tanke Biosciences have?

How much cash does Tanke Biosciences have on hand?

What is Tanke Biosciences’s dividend yield?

Premium Investing Services